Healthcare Insights

Image related to an article about Advanced Medical Solutions

Why Advanced Medical Solutions is a market favourite

Healthcare

Some shares have withstood recent economic shockwaves better than others - but is Advanced Medical Solutions (LON:AMS) one of them? To understand why different shares respond to chaos in different ways, it pays to look at their strengt...

LON:AMS

Image related to an article about Angle

Could Angle (LON:AGL) be a turtle trade?

Healthcare

Ever since the 1980s, when the now-infamous "Turtle Traders" beat the market with simple strategies based on breakouts to new high prices, momentum investing has been shown to be a potentially profitable strategy.  In fact, many academ...

LON:AGL

Image related to an article about Smith & Nephew

Which way now for the Smith & Nephew share price?

Healthcare

Geopolitical and economic turmoil has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from h...

LON:SN.

Image related to an article about Gooch & Housego

Analysts upbeat on the outlook for Gooch & Housego

Healthcare

The Gooch & Housego (LON:GHH) share price has risen by 2.00% over the past month and it’s currently trading at 918p. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will...

LON:GHH

Image related to an article about Benchmark Holdings

Analysts optimistic on Benchmark Holdings outlook

Healthcare

The Benchmark Holdings (LON:BMK) share price has risen by 4.35% over the past month and it’s currently trading at 48.0p. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will...

LON:BMK

Image related to an article about GSK

GlaxoSmithKline share price hits a new 52 week high

Healthcare

Shares in GlaxoSmithKline (LON:GSK) are currently trading close to a 52 week high, with the share price up by around 0.49% to 1,764p over the past week. On a one-month basis, the GlaxoSmithKline price has risen by 1.33%. For investors...

LON:GSK

Image related to an article about EMIS

Four signs of a competitive moat at EMIS (LON:EMIS)

Healthcare

Given that widespread uncertainty in the economy and the stock market is likely to endure for many months, it pays to know that you're investing in high-quality stocks, rather than speculative ones. This means safe, profitable companie...

LON:EMIS

Image related to an article about Genus

Which way now for the Genus share price?

Healthcare

Geopolitical and economic turmoil has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from h...

LON:GNS

Image related to an article about Abcam

Which way now for the Abcam share price?

Healthcare

Geopolitical and economic turmoil has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from h...

LON:ABC

Image related to an article about Healius

Healius passes these three dividend tests

Healthcare

With tens of billions paid out in dividends across the stock market each year, it's no surprise that investors pay close attention to the payouts from shares like Healius (ASX:HLS). The return 'boost' from cash payouts is a crucial par...

ASX:HLS

Image related to an article about CSL

What is the broker consensus view on CSL?

Healthcare

'Buy' and 'sell' recommendations from company analysts often catch the attention of investors - but it's worth remembering that city experts can get things wrong. So rather than relying on just one recommendation, a potentially better...

ASX:CSL

  • Quality
    76
  • Value
    83
  • Momentum
    68
  • StockRank™
    93

Unlock comprehensive stock market insights

Quickly sanity-check any investment idea, with a free trial of Stockopedia's award-winning research platform. Join over 15,000 investors who use Stockopedia to:

  • Access institutional-quality insights on thousands of stocks
  • Make more confident, successful investing decisions
  • Learn from the smartest investor community on the web
Get started for free

Absolutely Perfect

"Trialed multiple other platforms - this is by far my favourite. Other platforms do not even have half the stuff that you can find on Stockopedia. Love it!"